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Abstract
Liver regeneration (LR) after 70% partial hepatectomy
(PH) represents a unique in vivo model of cell cycle
and gene regulation. This study was conducted to
characterize apoptosis-associated gene expression
during LR. The results indicated that transcripts for
both bcl-x and bcl-2 exhibited similar patterns of
expression during LR with peaks at 6 h post-PH. In
contrast, the major I .1 -kb bax transcript exhibited
peaks at 18 (P < 0.05) and 72 h (P < 0.001) post-PH.
Nuclear run-on analyses for all three genes indicated
no detectable transcription rate changes during LR. At
6 h post-PH, when bcl-x mRNA levels were increased
by 25-fold (P < 0.001), bcl-x mRNA half-life was
elevated 4-fold (P < 0.001). Similarly, bax transcript
half-life increased from 2.8 h at 0 h to 4.3 h at 24 h
(P < 0.001) and >8 h at 40 h (P < 0.001) post-PH,
coincident with increases in steady-state levels of
mRNA. Western blot analyses of Bcl-2 and Bcl-x
proteins showed no significant change through 96 h of
LR, whereas Bax protein levels cycled in parallel with
its mRNA. Interestingly, novel Bax- and Bcl-2-cross-
reactive proteins of 31 and 32 kDa, respectively, were
detected in nuclei isolated from quiescent liver. When
liver growth was induced by the peroxisome
proliferator clofibrate, transcript and protein levels
were coupled for bcl-x but not for bar. In conclusion,
the apoptosis-associated genes bcl-2, bcl-x and bax
are modulated at the transcript and protein levels
during LR, suggesting a role for these gene products in
normal liver growth. The alterations in transcript levels
occur posttranscriptionally and involve changes in
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mRNA stability. Furthermore, unlike bax, steady-state
protein and transcript levels are uncoupled for both
bcl-2 and bcl-x, suggesting a role for translational
regulation during LR after PH.
Introduction
The phenomenon of cell death via shrinkage necrosis was
first described by Kerr in 1971 in regressing liver following
portal vein ligation. This was followed by its further charac-
terization and the elucidation of its biological importance in a
subsequent article by Kerr et a!. (1), in which the term apop-
tosis was used to define this distinctive mode of “pro-
grammed cell death.” Apoptosis is an important process by
which organisms are able to eliminate damaged, precancer-
ous or excessive cells in the absence of an inflammatory
response. It plays a pivotal role in cell death during devel-
opment of embryonic tissue and during the natural death of
differentiated cells. It is characterized by very specific mor-
phological, biochemical, and molecular changes within the
cell (2). Cells undergoing apoptosis typically exhibit conden-
sation of chromatin and cytoplasm, subsequent fragmenta-
tion of the nucleus, and formation and shedding of “apop-
totic bodies.” The characteristic apoptotic bodies consist of
nuclear and cytoplasmic components with intact cell or-
ganelles surrounded by plasma membrane. A key biochem-
ical event in apoptosis is endonucleolysis, in which nuclear
DNA is degraded into fragments equivalent to single or mul-
tiple nucleosomes, which can be observed as the typical
“ladder” formation following agarose gel electrophoresis (3).
The ability of hepatocytes to undergo apoptosis in vivo has
been shown to occur in normal liver, particularly in those cells
adjacent to the terminal hepatic veins (4). Hepatocytes are
also eliminated through apoptosis in vivo in response to
withdrawal of peroxisome proliferative agents (5) and to ex-
ogenous administration of numerous compounds, including
cycloheximide (6) and transforming growth factor f31 (7).
Little is known, however, about the molecular pathway(s) by
which hepatocytes undergo apoptosis, although overexpres-
sion of the proto-oncogene c-myc induces apoptosis in a
hepatoma cell line in vitro (8). Bcl-2, bcl-x, and bax are
members of a growing family of genes that are involved in
promoting either cell survival or cell death via apoptosis (9).
However, the regulation of these genes during normal hep-
atocyte growth has not been established.
The adult mammalian liver represents an organ composed
of long-lived, terminally differentiated cells; unlike other tis-
sues of this type, the liver is able to undergo compensatory
hyperplasia after removal of 70% of its mass (1 0). Following
surgical resection, two waves of cell replication occur, which
include significant peaks in DNA synthesis around 24 andTime Post-PH (h)
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Fig. 1 . Steady-state mANA levels and transcriptional activity of the bcl-2
gene during LA. a, relative amounts of steady-state mANA during the first
96 h post-PH and in isolated primary hepatocytes. Representative North-
em blot of 15 jig/lane poly(A) ￿ -enriched RNA hybridized with a radiola-
beled fragment of the rat bcl-2 cDNA as described in “Materials and
Methods.” Transcript sizes are indicated on the right. The accompanying
graph depicts the mean of three separate experiments (bars, SD) showing
the change in steady-state mRNA levels of the 3.0-kb transcript relative to
pre-PH (0 h) through 96 h of LA. A significant decrease in transcript
expression relative to zero time occurred between 6 and 84 h post-PH
(P < 0.001). b, relative transcriptional activity of the bcl-2 gene during the
first 42 h post-PH. Nuclei were isolated from remnant livers, and 32P-
labeled RNA was generated using the nuclear run-on assay described in
“Materials and Methods.” The radiolabeled RNA nuclear run-on products
from the indicated times post-PH were hybridized to nylon membranes to
which 3 jig of the cDNAs for bcl-2, pGEM -3Z, ASGPR, and c-myc were
bound by slot blot. The results shown are representative of three separate
experiments. Hep, isolated primary hepatocytes.
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48 h post-PH.4 The initial S-phase represents predominantly
hepatocyte DNA replication, and the second S-phase results
from that of both hepatocyte and nonparenchymal cells. In
young rats, as many as 95% of the hepatocytes replicate
during this time period, thus providing a unique in vivo model
to study the cell cycle and gene regulation in differentiated
cells. In this study, we investigated the expression of bcl-2,
bcl-x, and bax during the first 96 h post-PH to determine
whether these genes were modulated during the cell cycle in
vivo. In addition, we also examined their expression during
liver growth induced by the peroxisome proliferator clofi-
brate. This type of growth differs from that observed post-PH
in that it does not exhibit increased expression of hepatocyte
growth factor mRNA in the liver (1 1) or increased expression
of immediate-early genes such as c-fos and c-jun (12). Also,
the increased liver mass is rapidly eliminated by apoptotic
cell death following withdrawal of the mitogen (5, 7).
We report here that expression of these genes is modu-
lated during at least two well-characterized cell cycles in the
regenerating liver after PH. In contrast to in vitro studies (13,
14), steady-state transcript levels of these genes are con-
trolled by posttranscriptional mechanisms and involve alter-
ations in mRNA stability in some cases. Furthermore, West-
em blot analyses indicated that bax protein and transcript
expression patterns remain coupled through the regenera-
tive period. This was in contrast to bcl-x and bcl-2, which
exhibited significant uncoupling, suggesting translational
and/or posttranslational regulation of these genes during LR.
Interestingly, bax but not bcl-x transcript and protein levels
were uncoupled in the model of liver growth induced by
clofibrate. Finally, induction of hepatocyte apoptosis in vivo
by withdrawal of clofibrate was associated with coupling of
protein and mRNA steady-state levels for both bax and bcl-x.
The results suggested that regulation of bcl-x and bax gene
expression in hepatocytes apparently occurs differently dur-
ing proliferation and apoptosis.
Results
Bcl-2 Transcript Expression during LR. The mRNA
steady-state transcript levels for bcl-2 were investigated by
Northern blot analysis through the first 96 h following 70%
PH (Fig. la). Similar to human cells (15), three different bcl-2
transcript species were expressed in rat liver, a major band
at 3.0 kb and two minor bands at 4.4 and 7.5 kb. All three
mRNAs were expressed at very low abundance in rat liver
but were modulated in parallel during the regenerative pe-
nod. The major 3-kb transcript increased approximately 1.5-
fold over pre-PH (0 h) levels by 6 h post-PH and then do-
creased dramatically by 18 h to less than 20% of baseline
values. The transcript levels began to increase again at 42 h
post-PH and returned to baseline values by 96 h.
The low abundance of the bcl-2 transcripts observed in rat
liver was felt to be due in part to a lack of their expression by
hepatocytes. To confirm this, poly(A)￿-enriched RNA was
4 The abbreviations used are: PH, partial hepatectomy; ASGPR, asialo-
glycoprotein receptor; LA, liver regeneration; nt, nucleotide; poly(A),
polyadenylated.
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prepared from primary rat hepatocytes isolated by standard
collagenase perfusion and was subjected to Northern blot
analysis. The results indicated that the bcl-2 transcripts ob-
served in total liver poly(A) p-enriched RNA were, in fact,
unique to nonparenchymal cells because no detectable bcl-2
transcripts were observed in the RNA isolated from hepato-
cytes (Fig. la). The results are consistent with previous im-
munohistochemical reports that Bcl-2 protein was detecta-
ble only in nonparenchymal cells of liver (16).
Nuclear run-on analyses were performed to determine the
role of transcriptional mechanisms in the control of bcl-2
gene expression in the liver before and after PH. The results
of the analyses at several time points post-PH indicated no
detectable alterations in transcription rate of bcl-2 (Fig. lb),
whereas the control c-myc exhibited the characteristic 4-fold
increase in transcriptional activity at 6 h post-PH (17). Thus,Time Post-PH (h)
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Fig. 2. Alterations in bcl-x gene expression and mRNA half-life during
LR. a, representative Northern blot of 5 jig/lane of poly(A)￿-enriched RNA
hybridized with a radiolabeled fragment of the murine bcl-x cDNA. Tran-
script size is indicated on the right. The accompanying graph depicts the
changes in steady-state transcript levels relative to pre-PH through 96 h
post-PH and represents the mean of three separate experiments (bars,
SD). The transcript was significantly increased at 3 and 6 h relative to
pre-PH values (P < 0.001). b, transcriptional rate analyses of the gene
encoding bcl-x indicated no detectable change during the first 42 h of
regeneration. The nuclei were isolated, and 32P-Iabeled RNA run-on prod-
ucts were obtained for hybridization as described in the legend to Fig. 1
and “Materials and Methods.” Slot blots and autoradiograms were pro-
cessed as described in Fig. 1. The results shown are representative of
three separate experiments. c, in vivo half-life (t112) determinations of bcl-x
in pre-PH (0 h) and regenerating liver. Rats were injected with actmnomycmn
D and a-amanitin as described in “Materials and Methods” at 0, 6, and
12 h post-PH. PoIy(A)￿-enriched RNA was prepared from remnant tissue
harvested at the indicated times postinjection and subjected to Northern
blot analysis. The apparent half-lives determined by linear regression
analysis are depicted in the graphs at 0 (), 6 (4), and 12 (#{149}) h post-PH.
Data points, mean of at least three separate experiments; bars, SD. Hep,
isolated primary hepatocytes.
Time (mm)
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the modulation of the steady-state transcript levels post-PH
observed for bcl-2 occurs primarily at the posttranscriptional
level.
Effects of LR on mRNA Expression and Transcript Sta-
bility of bcl-x. Northern blot analysis using a murine cDNA
probe revealed significant changes in mRNA expression of
the single 3.2-kb bcl-x transcript during the first 96 h post-
PH. Transcript levels increased 20-fold over control levels by
3 h post-PH, exhibited a peak 25-fold increase at 6 h, and
then declined sharply to 3-fold over baseline levels by 12 h
post-PH (Fig. 2a). The bcl-x steady-state mRNA levels re-
mained moderately elevated over pro-PH values for the re-
mainder of the regenerative period beyond 12 h. To deter-
mine whether the 3.2-kb bcl-x transcript observed in RNA
isolated from the liver was produced by parenchymal cells,
Northern blot analysis of isolated hepatocyte poIy(A)￿-en-
riched RNA was performed. The results indicated that the
bcl-x transcript observed in the liver RNA samples was pro-
duced by hepatocytes because a similar abundance of the
transcript was detected in equivalent amounts of total liver
and hepatocyte poly(A)￿-enriched RNA (Fig. 2a).
Nuclear run-on assays were performed to assess the role
of transcription in the modulation of steady-state transcript
abundance for bcl-x. Interestingly, no detectable changes in
transcriptional activity were observed (Fig. 2b) through 42 h
of regeneration. The invariant transcription rate for this gene
suggested that, similar to bcl-2, posttranscriptional events
were responsible for the observed changes in steady-state
transcript levels after PH. To establish whether altered mRNA
stability might account for the observed modulations in
steady-state transcript levels, in vivo mRNA half-life deter-
minations at 0 h and times corresponding to altered tran-
script abundance were performed. Transcriptional inhibition
was accomplished using a combination of a-amanitin and
actinomycin D at 0, 6, and 12 h post-PH (18). The poIy(A)￿-
enriched RNA isolated from these samples was subjected to
Northern blot analysis, and the autoradiograms were quan-
titated densitometrically using the ASGPR transcript as the
normalization control. Linear regression analysis indicated
that alterations in steady-state mRNA levels for bcl-x were
associated with changes in mRNA half-life (Fig. 2c). At a time
of increased steady-state transcript abundance, bcl-x exhib-
ited a 4-fold increase in message stability (t112 = 106 mm at
6 h post-PH) relative to its pro-PH half-life of 27 mm (P <
0.001). The half-life of bcl-x retumed to that observed pre-PH
when the transcript abundance decreased sharply at 12 h
post-PH. Thus, posttranscriptional mechanisms involving al-
terations in transcript stability were, in part, responsible for
the modulation in steady-state mRNA abundance exhibited
by bcl-x during LR. However, the alteration in half-life ob-
served at 6 h post-PH was insufficient to fully account for the
25-fold increase in transcript levels, suggesting the involve-
ment of additional posttranscriptional mechanisms.
Alterations in bax Gene Expression and mRNA Half-
Lives during LR. Both the major 1 .1 -kb and minor 2.9-kb
transcript species expressed by bax in rat liver exhibited
changes in steady-state transcript levels during 96 h of re-
generation (Fig. 3a). However, the two transcripts exhibited
quite different patterns of expression. The canonical 1.1 -kb
a Time Post-PH (h)
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bax transcript exhibited a small 6-fold increase over baseline
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between 24 and 36 h post-PH. By 42 h post-PH, transcript
abundance increased to a level greater than that at 18 h; it
continued to increase and peaked at 72 h post-PH, 12-fold
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transcript was equally abundant in both RNA samples, sug-
gesting that the hepatocyte was the primary cell of expres-
sion (Fig. 3a).
Similar to bcl-2 and bcl-x, no significant changes in tran-
scriptional activity were observed for bax through 42 h of
regeneration (Fig. 3b). The decay rate of the 1 .1 -kb bax
species was determined at 0, 24, and 40 h post-PH using the
combination of transcriptional inhibitors a-amanitin and ac-
tinomycin D (Fig. 3c). Linear regression analysis of data
derived from Northern blot autoradiograms and normalized
to the ASGPR transcript indicated a 1.5-fold increase in bax
transcript stability at 24 h post-PH (t112 = 4.3 h) relative to 0 h
(t112 2.84 h; P < 0.001) and a 3-fold increase in the bax
mRNA half-life to >8 h at 40 h post-PH (P < 0.001). However,
the changes in half-life between 0, 24, and 40 h post-PH
could not fully account for the differences observed in tran-
script steady-state levels.
Species Differences in Apparent Molecular Mass of
Bax and Bcl-2 in Liver. The expression of the bax, bcl-2,
and bcl-x gene products was characterized in quiescent rat,
mouse, and human liver using multiple polyclonal antibodies
to the corresponding proteins. No differences in apparent
molecular mass between the three species were observed
for Bcl-x (data not shown). Bax exhibited an apparent mo-
lecular mass of 23 kDa in both rat and mouse, in contrast to
the 21-kDa protein detected in normal human liver (Fig. 4).
Two additional minor cross-reactive bands were observed in
control rat liver at 28 and 31 kDa. BcI-2 exhibited three
cross-reactive bands in all species (Fig. 4). Two minor protein
products 29 and 32 kDa were observed in all three species,
cellular origin of the 1.1 -kb bax transcript observed in the
liver RNA samples was investigated using Northern blot anal-
ysis of poly(A)￿-enriched RNA samples from isolated hepa-
tocytes and whole liver. Similar to bcl-x, the 1 .1 -kb bax
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Fig. 3. Alterations in mRNA stability and steady-state transcript levels for
bax post-PH. a, representative Northern blot of poly(A)￿-enriched RNA (5
jig￿ane)was hybridized with a￿P-labeIed fragment ofthe murinebax cDN￿
Transcript sizes are indicated on the right. The accompanying graph depicts
the changes in mRNA levels relative to pre-PH through 96 h post-PH of the
major 1.1-kb transcript. Data points, mean of three experiments; bars, SD.
Significant alteration in the 1.1 -kb mRNA steady-state levels relative to zero
time occurred at 18 (P < 0.01) and 42-84 h (P < 0.001) post-PH. b,
transcription￿ rate an￿yses of the gene encoding bar were determined
through 42 h of regeneration. The nucl￿ were isolated, and ￿P-labeled RNA
run-on products were obtaffied for hybridization from the indicated times as
described in Fig. 1 and “Materials and Methods.” Skt blots and autoradk-
grams were processed as described in the legend to Fig. 1 . The results are
representative of three separate experiments. c, in vivo half-lives ofthe 1.1-kb
transcript for bax in pre-PH (0 h) and regenerating liver were determined. At
0 (N), 24(A), and 40(#{149}) h post-PH, rats were injected with actinornycin D and
a-amanftin. PoIy(￿6￿-enriched RNA from remnant tissue harvested at the
indicated times postinjection was analyzed by Northern blot. The apparent
half-lives determined by linear regression analysis are depicted in the graph.
Data points, mean of at least three separate experiments; bars, SD; Hap,
isolated primary hepatocytes.
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Fig. 4. Apparent molecular masses of Bax and Bcl-2 in liver from rat,
mouse, and human. Total protein w&. isolated from rat, mouse, and
human liver and was subjected to Westem blot analysis for Bax (150
jig/lane) and Bcl-2 (100 jig/lane) as described in “Materials and Methods.”
The representative immunoblots of Bax indicate apparent molecular
masses of 23 kDa for both rat and mouse and 21 kDa for human. Rat BcI-2
had an apparent molecular mass of 27 kDa, whereas both mouse and
human exhibited masses of 25 kDa protein. Molecular mass standards are
indicated on the right. R, rat; M, mouse; H, human.Cell Growth & Differentiation 1637
whereas the major polypeptide for both mouse and human
was mapped at 25 kDa, and the major rat protein exhibited
a molecular mass of 27 kDa.
Expression of Bax, Bcl-2, and Bcl-X during Rat LR. The
steady-state levels of the apoptosis-associated proteins
Bax, BcI-2, and BcI-x in regenerating rat liver after 70% PH
were characterized using immunoblot analysis. Cytoplasmic
proteins were isolated from the indicated times through 96 h
post-PH and analyzed for protein expression using various
monoclonal and polyclonal antibodies. Cytoplasmic protein
was used because it showed equivalent abundance of the
major protein products for all three genes as the total protein
extract (data not shown). Bax steady-state protein levels
were modulated during LR and exhibited an expression pat-
tern that roughly mirrored that of the 1 .1 -kb transcript (Fig. 5).
Levels began to increase at 18 h, and an initial peak over
pre-PH values occurred at 24 h post-PH. Protein levels de-
creased between 30 and 36 h, then increased 3.5-fold over
control by 42 h (P < 0.001). Bax levels then declined slightly
through 60 h before increasing to 4.5-fold over 0 h levels (P <
0.001) and remained elevated through 96 h. In contrast, both
BcI-2 and BcI-x protein levels were uncoupled from their
respective transcript levels, exhibiting little modulation rela-
tive to their initial pre-PH values during the 96 h period of
regeneration (Fig. 5). However, there was a reproducible but
statistically insignificant decrease in both of their steady-
state levels at 36 to 42 h post-PH, which always occurred
simultaneously.
Nuclear Localization of Bax and Bcl-2 Cross-Reactive
Proteins in Rat Liver. The cytosolic protein immunoblots
(Fig. 5) for both Bax and Bcl-2 consistently lacked the up-
permost protein species detected in total protein isolates
(Fig. 4). To determine whether these protein species were
nuclear in origin, whole nuclei were isolated, and the outer
nuclear envelope was removed. Soluble nuclear proteins and
the remaining unextractable material were analyzed by West-
em blot using two different antibodies. A Bax cross-reactive
protein of 31 kDa was detected in the nuclear material re-
maining after extraction (Fig. 6). A 32-kDa Bcl-2 cross-reac-
tive protein was detected in the total nuclear material remain-
ing after removal of the outer nuclear envelope (Fig. 7). The
BcI-2 and Bax cross-reactive nuclear proteins were also
detected in nuclear isolates from rat heart, spleen, kidney,
and intestine (data not shown). Also, the expression pattern
post-PH for the 32-kDa BcI-2 cross-reactive protein mirrored
that of its canonical cytoplasmic protein. In contrast, the
31 -kDa nuclear cross-reactive species for Bax exhibited no
detectable modulation in steady-state levels compared to
that of the cytoplasmic 23-kDa protein (data not shown).
Expression of bax and bcl-x during Mitogen-induced
Liver Growth and Apoptosis. To compare the expression
of bcl-x and bax in a different model of hepatic growth,
animals were treated with the peroxisome proliferator clofi-
brate. Rats gavaged with the mitogen for 10 days displayed
a significant 56.6 ± 7.1 % increase in liver mass relative to
untreated controls (P < 0.001). After withdrawal of clofibrate
for 53 h, the liver mass decreased 19% (P < 0.01), coincident
with peak levels in apoptosis (5). Treatment with clofibrate
decreased both steady-state transcript and steady-state
protein levels for bcl-x to 11 ± 6 and 15 ± 3% of control
levels (P < 0.001), respectively (Fig. 8, right panel). Interest-
ingly, withdrawal of the mitogenic stimulus did not substan-
tially increase either the transcript or protein steady-state
levels, which remained at 16 ± 5 and 19 ± 3%, respectively.
In contrast, bax transcript levels remained at untreated con-
trol values in all clofibrate-treated animals (Fig. 8, left panel).
However, the abundance of Bax protein declined signifi-
cantly to 19 ± 3% of control values (P < 0.001) in the
clofibrate-treated rats. After discontinuing clofibrate and dur-
ing maximum apoptosis, Bax increased to baseline levels.
Discussion
The present study was performed to examine changes in ex-
pression of the apoptosis-associated genes bcl-2, bcl-x, and
bax dunng proliferation of differentiated hepatocytes in vivo. We
determined that the transcript expression of these genes is
regulated posttranscriptionally and, at least in part, by changes
in mRNA stability. Furthermore, both bcl-2 and bcl-x exhibited
notable uncoupling of mRNA and protein expression in the
regenerating liver after PH. The low abundance of bcl-2 tran-
script in poly(A)￿-ennched RNA from rat liver and its absence in
isolated hepatocytes agree with previous immunohistochemi-
cal studies in both human (19) and rodent tissues (16, 20).
Interestingly, the marked decrease in mANA during the G1
phase of the nonparenchymal cells post-PH and its return to
baseline levels subsequent to their major replicative phases at
42-48 and 72 h (10) suggests a cell cycle-dependent.regulation
of transcript expression. The lack of detectable transcriptional
rate changes at times reflecting altered steady-state transcript
abundance during LA was surprising because bcl-2 transcript
levels were shown to be transcnptionally regulated in cultured
cell lines (13). However, numerous examples now exist of genes
that exhibit transcriptional regulation in cell culture systems and
during development but are controlled posttranscnptionally in
the regenerating liver after PH (17). Moreover, the nuclear
run-on assay used to determine transcriptional rates only
measures elongation of nascent transcripts. It cannot repro-
duce certain synthetic activities unique to RNA polymerase II,
such as rate-limiting promoter proximal pausing (21). Thus, if
these postinitiation rate-limiting steps are regulated during LA,
we would not detect those changes using the standard assay.
The uncoupling observed between the steady-state tran-
script and protein levels for bcl-2 in the regenerating liver sug-
gests additional regulation involving translational and/or post-
translational mechanisms. This notion is consistent with the
reported inverse distribution of bcl-2 mANA and protein levels
determined in situ in normal human lymphoid tissue (22), mdi-
cating translational and/or posttranslational control of Bcl-2
protein levels. In addition, the detection of the 32-kDa Bcl-2
cross-reactive nuclear protein in human, murine, and rat liver
suggests that it may play a similar role in all species. In fact, it
may also be associated with chromatin, as was recently re-
ported for Bcl-2 in epithelial cells undergoing mitosis (23).
The absence of a bcl-2 transcript in hepatocytes contrasts
with the expression of the related gene bcl-x. This homo-
logue has been shown to localize to similar subcellular com-
partments (24-26), form heteromeric complexes with many
of the same partner proteins (27, 28), and compensate in0 6 12 18 24 30 36 42 48 54 60 72 84 96
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Fig. 5. Bax, Bcl-2, and Bcl-x protein
expression in regenerating rat liver. Cy-
toplasmic proteins were isolated from
livers at the indicated times post-PH
and resolved by SDS-PAGE. Immuno-
blots (100 jig/lane) of Bax, BcI-2, and
BcI-x expression were determined us-
ing monoclonal and polyclonal anti-
bodies as described in “Materials and
Methods.” The protein molecular
masses are indicated on the right. All
experiments were repeated on four
separate animal sets, and the fluoro-
grams were quantitated as described
in “Materials and Methods.” The ac-
companying histograms depict the
mean changes t SD in steady-state
protein levels relative to zero time
through 96 h of LA. *, significantly dif-
ferent from 0 h (P < 0.001); ￿, signifi-
cantly different from 72 h (P < 0.05,
42 h; all others, P < 0.001).
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Fig. 6. Nuclear localization of a Bax cross-reactive protein in rat liver.
Pure nuclei were isolated from pre-PH rat liver, and the outer nuclear
membrane was removed from a portion as described in “Materials and
Methods.” Nuclear extract, insoluble nuclear material, and cytoplasmic
lysate were analyzed by Western blot using an anti-Bax polyclonal anti-
body. The molecular mass standards are indicated on the right. Lane 1, 50
jig of 0 h cytoplasmic protein: Lane 2, 50 jig of nuclear extract from nuclei
stripped of the outer nuclear membrane; Lane 3, insoluble material equiv-
alent in volume to 50 jig of nuclear extract; Lane 4, 50 jig of nuclear
extract; Lane 5, insoluble material equivalent in volume to the same 50 jig
amount of nuclear extract. An apparent molecular mass of 31 kDa was
determined for the Bax cross-reactive protein. The determination was
done on two different animals using two different polyclonal antibodies
with identical results.
\￿ ,￿,
I I ￿ ,
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Fig. 8. Expression of bcl-x and bax during clofibrate-induced liver
growth and apoptosis. Aepresentative Northern (top panel) and Western
(bottom panel) blots of bcl-x (left) and bax (right) steady-state transcript
and protein levels in rats treated with clofibrate as described in “Materials
and Methods.” Poly(A) ‘ -enriched ANA (5 jig/lane) and cytoplasmic pro-
tein (125 jig/lane) used for the Northern and Western blots were isolated,
and the blots were processed as described in the legends to Figs. 2, 3,
and 5. Quantitation of the autoradiograms and fluorograms as well as
normalization were performed as described in “Materials and Methods.”
Transcript sizes and molecular mass markers are indicated on the right.
The results represent a minimum of three separate animals per group.
T CN
-3OkD
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Fig. 7. A nuclear-associated Bcl-2 cross-reactive protein in rat liver.
Total, cytoplasmic, and nuclear protein isolated from 0 h liver as outlined
in “Materials and Methods” was subjected to Western blot analysis. The
proteins on the representative immunoblots were detected with two dif-
ferent polyclonal antibodies against Bcl-2 and visualized using enhanced
chemiluminescence. Molecular mass markers are indicated on the right.
The nuclear associated Bcl-2 cross-reactive protein exhibits an apparent
molecular mass of 32 kDa. Identical results were obtained from at least
three separate experiments. T, total protein; C, cytoplasmic protein: N,
nuclear protein.
vitro for decreased bcl-2 expression (29). Like bcl-2, it has
been reported that alternative splicing of the bcl-x gene is
responsible for multiple protein species (24, 30). However, in
contrast to bcl-2, in which the truncated form of the protein
functions ineffectively to protect against apoptosis (31), the
shorter Bcl-x protein, Bcl-x￿, effectively promotes cell death
(30). The detection of a single transcript species for bcl-x in
rat liver and only the larger 27.6-kDa Bcl-xL protein product
concurs with previous reports that the bcl-xL species is the
major bcl-x mRNA expressed in embryonic and adult murine
tissues (24, 25). However, low levels of bcI-x￿ transcripts
have been detected in human and murine liver using PCR
amplification (32). Additionally, the presence of bcl-x tran-
script in isolated hepatocytes is consistent with the in vivo
hepatocytes (26). In short, these observations suggest that
the functional role(s) performed by Bcl-2 in other cell types
may be fulfilled by Bcl-xL in hepatocytes. However, these
two proteins do not function identically, as is particularly
obvious by the in utero death of bcI-x￿ mice (33) in contrast
to the survival of bcI-2￿ homozygous mice for as long as 19
weeks after birth (34).
The dramatic increase in bcl-xL mRNA observed in regen-
erating rat liver occurred during the G0 to G1 transition. This
is coincident with increased steady-state levels of c-myc and
other immediate-early genes (35), suggesting that it may play
a role in GcJG1 transition or “priming” of hepatocytes into a
replication competent state. The modulation of bcl-x mRNA
during this time period appears to occur posttranscriptionally
because no detectable transcriptional rate changes were
observed. The change in transcript half-life for bcl-x mdi-
cated that mRNA stability is at least one posttranscriptional
mechanism involved in regulating its steady-state levels fol-
lowing PH. The short half-life of the bcl-x transcript observed
pro-PH and 12 h post-PH (26 mm) is in contrast to the -2.75
h half-life reported for bcl-2 in lectin-stimulated normal lym-
phocytes in vitro (1 3). However, the lability of this mRNA is
consistent with that of many of the immediate-early genes,
such as c-fos, c-jun, and c-myc, observed in cultured cells
(36). The 4-fold increase in stability of the bcl-x transcript
observed at 6 h post-PH cannot completely account for the
coincident 25-fold increase in steady-state mRNA levels. It is
possible that the increase in transcript stability at 6 h was
underestimated as a result of pleiotropic inhibition of tran-
scription resulting in the loss of labile factors involved in
mRNA decay (36). However, we cannot rule out the possi-
bility that other posttranscriptional mechanisms are also in-
volved, including processing of heterogeneous nRNA (37, 38)
and nucleocytoplasmic transport of mature RNA (39).
The uncoupling of transcript and protein steady-state levels
for bc/-xL suggests that translational or posttranslational control
of protein steady-state levels occurs during LR following PH.
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this in vivo model of cell cycle progression, i.e., retinoblastoma
and p53 (40), cyclins A and Dl (41 , 42), cyclin B1 (43, 44), as
well as proliferating cell nuclear antigen and thymidine kinase
(43, 45). These results suggest that in vivo translational and/or
posttranslational control of protein steady-state levels may be a
critical factor involved in controlling cellular protein levels during
normal cell proliferation.
The expression of the 1.1-kb bax mANA steady-state 1ev-
els during LA parallels the major growth period of the liver
until 72 h post-PH (35). Its presence in poly(A)￿-enriched
RNA from isolated hepatocytes is consistent with in vivo
immunohistochemical localization of the protein in murine
hepatocytes (1 6). In contrast to the results observed in cul-
tured cell lines (14), the increase in bax mRNA steady-state
levels following PH occurred in the absence of detectable
transcription rate changes. The increased half-life of the
1 .1 -kb bax mANA at 24 and 40 h post-PH further establishes
that alteration of the decay rate of the transcript is one
posttranscriptional mechanism involved in controlling its
abundance during LR.
In contrast to both bcl-2 and bcl-x, the steady-state tran-
script and protein levels for bax appeared to be coupled during
the regenerative period. Bax has been shown to dimerize of-
fectively with BcI-x1 protein in both yeast two-hybrid and cul-
tured cell systems, in which heterodimerization results in cell
survival and Bax homodimerization results in cell death via
apoptosis (27, 28). The large increase in Bax abundance 72 h
post-PH occurs during the initial stages of microarchitectural
remodeling in the liver (46), suggesting that apoptosis of hepa-
tocytes may be required for this process. However, PH has
been shown to significantly decrease the number of hepato-
cytes undergoing apoptosis (47), implying that the increase in
Bax protein may exhibit some other function in these newly
replicated cells. It is conceivable that Bax expression functions
to reestablish sufficient protein levels for hepatocytes to resume
their “primed” apoptosis status (48). Primed cells have all the
necessary effector molecules present for immediate apoptosis
and thus are able to complete the molecular sequence of
events required for apoptosis without new gene activation.
Hepatocytes undergoing apoptosis in vivo fit these criteria,
completing all stages of apoptosis in -3 h (49), even in the
absence of protein synthesis (6). The pattern of Bax expression
during LA is consistent with this possibility because its peaks in
protein expression followed the first and second waves of he-
patic mitosis.
The induction of an additional 2.9-kb bax transcript by 3 h
post-PH suggests that another spliced variant of bax occurs
during replication of these differentiated cells in vivo. This
novel form of the bax transcript has not been previously
reported, although alternatively spliced transcripts of bax
resulting in an additional 1 .5-kb species have been charac-
terized (19). It is interesting that this 2.9-kb transcript species
is absent in the quiescent liver and its pattern of steady-state
expression is different from that observed for the canonical
1.1 -kb bax transcript. The length of this mANA is sufficient to
encode either the 28-kDa cytosolic or the 31-kDa nuclear
cross-reactive Bax polypeptide observed in rat liver, yet nei-
thor expression pattern for these proteins mirrored that of the
2.9-kb transcript. The detection of a novel 31 -kDa Bax cross-
reactive peptide in the nuclear material remaining after ex-
traction of the nuclear proteins suggests that, like Bcl-2 (23),
this protein may be associated with chromatin. However, the
levels of this protein did not appear to fluctuate during the
proliferative period examined.
Unlike LA after PH, bcl-x mRNA and protein levels were
coupled during mitogen-induced liver growth, whereas bax
protein levels decreased with no corresponding change in
transcript expression. Differences in expression of these two
genes may result from a number of factors, including the
increased ploidy associated with clofibrate-induced hepatic
growth (50). In contrast to the proliferative state, Bax re-
turned to baseline levels following clofibrate withdrawal.
Thus, both bax and bcl-x mRNA and protein steady-state
levels were coupled in apoptotic regressing livers. The al-
tered ratio of BcI-x to Bax in the animals withdrawn from
clofibrate suggests that this perturbation may be responsible
for the observed apoptosis.
In conclusion, it is well established that bcl-2, bcl-x and
bax gene expression are modulated with cell differentiation
and their protein products are involved in apoptosis regula-
tion. This study suggests that in differentiated hepatocytes in
vivo, they also exhibit a potential role in normal cellular pro-
liferation or in maintaining the survival of proliferating hepa-
tocytes. Furthermore, their steady-state transcript abun-
dance is regulated posttranscriptionally and at least in part
by modulation of mRNA stability. Translational or posttrans-
lational control of Bcl-2 and Bcl-x protein levels, as sug-
gested by the apparent uncoupling of their RNA and protein
levels, supports the importance of cytoplasmic activity in
governing the overall function of a cell. Finally, the hepatic
expression of these genes appears to be controlled differ-
ently in response to proliferation versus apoptosis.
Materials and Methods
Materials. Rainbow colored protein molecular weight markers, Hy-
bond-C nitrocellulose membrane, ECL detection solutions, and the
[a-32P]dCTP and [a-32P]UTP were obtained from Amersham Life Science,
Inc, Arlington Heights, IL The GENE CLEAN II kit was from BlO 101 , nc,
La Jolla, CA. Actinomycin D, a-amanitin, guanidmne isothiocyanate, and
the random primed DNA labeling kit were from Boehringer Mannheim
Corp., Indianapolis, IN. Agarose and RNA standards were from Ufe Tech-
nologies, Inc., Gaithersburg, MD. Restriction endonucleases and oligo(dT)
cellulose were purchased from New England Biolabs, Inc., Beveriy, MA.
Sodium sarkosyl was obtained from International Biotechnologies, Inc.,
New Haven, CT. ReflectionTM NEF - 496 autoradiography film and Re-
flection￿ NEF - 491 intensifying screens were from Du Pont NEN#{174}
Research Products, Boston, MA. MSI MagnaGraph membrane was pur-
chased from Micron Separations, Inc., Westboro, MA. RQ1 DNase and
pGEM -3Z were purchased from Promega Corp., Madison, WI. Sucrose,
3-(N-morpholmno)propanesulfonic acid, and Tris base were obtained from
United States Biochemical Corp., Cleveland, OH. All normal sera were
purchased from Jackson lmmunoResearch Laboratories, Inc., West
Grove, PA. Goat antirabbit IgG peroxidase conjugate was purchased from
Sigma Chemical Co., St. Louis, MO. Clofibrate was obtained from Fluka
Chemical Corp., Ronkonkoma, NV. All other chemicals were molecular
biology or reagent grade and purchased from Aldrich Chemical Company,
Milwaukee, WI, Curtin Matheson Scientific, Inc., Eden Prairie, MN, Fischer
Scientific, Itasca, IL and Sigma Chemical Company, St. Louis, MO.
Animals and Surgical Procedures. Male Sprague-Dawley rats (Har-
Ian Sprague-Dawley, Inc., Indianapolis, IN) weighing 225-275 g were
maintained on a 12 h light-dark cycle and fed standard laboratory chow.
Seventy percent PHs were performed under ether anesthesia between
8 am. and noon as described (51). At various times post-PH, the animalsCell Growth & Differentiation 1641
were sacrificed, the liver tissue removed, rinsed in normal saline, and flash
frozen in liquid nitrogen. Animals used for the mRNA half-life determina-
tions were treated with a-amanitin and actmnomycmn D at either 0, 6, 12, 24,
or 40 h post-PH, as previously described (17). The animals were sacrificed
at various times postinjection as indicated in the Fig. legends and the
livers removed and processed as described above. The clofibrate-treated
animals received 500 mg/kg b.w. of the mitogen in mid-morning by
gavage for 10 days. They were then sacrificed and hepatic tissue re-
moved, weighed and processed as described above. An additional group
of animals was sacrificed 53 h after receiving the last dose of clofibrate.
Primary hepatocytes were isolated by standard collagenase digestion as
previously described (40).
All animals received humane care in compliance with the institute’s guide-
lines as outlined in “Guide for the Care and Use of Laboratory Animals”
prepared by the National Academy of Sciences and published by the Na-
tional Institutes of Health (NIH publication no. 86-23, revised 1985).
Northern Blot Analysis. Total RNA was isolated from frozen tissue by
the method of Chomczynski and Sacchi (52). Total and poIy(A)￿ enriched
RNA, obtained by oligo(dT) chromatography, was prepared for Northern
blot analysis as described previously (1 7). Transcript sizes were deter-
mined with a molecular weight RNAladderfrom BRL Probes were labeled
with [a-32P]dCTP (3,000 Ci/mmol) by random priming according to the
manufacturer’s specifications. Membranes were hybridized for 18-24 h at
42”C under stringent or moderate conditions for homologous or heterol-
ogous probes, respectively, and processed posthybridization as previ-
ously described (17). Autoradiography was done with Du Pont NEN Re-
flection film at - 70”C using an intensifying screen. Several exposures
were taken to ensure linearity of the films for densitometric analysis. The
Northern blots for bc!-2 were exposed approximately 5 times as long (8
days versus 40 h) as those for bcl-x and bax.
Hybridization Probes. The following cDNA fragments were used as
hybridization probes: the rat ASGPR 900-nt Pstl fragment, the 350-nt
PstI-BamHl fragment of the rat bcl-2 cDNA (53), the 680-nt SalI-BgIIl
fragment ofthe murine bc!-x cDNA(24), and the 943-nt EcoRl fragment of
the murine bax cDNA (19).
Transcriptional Rate Analysis. Isolation of nuclei and transcriptional
rate assays were performed as described previously (1 8) with modifica-
tions. MagnaGraph nylon membranes, to which 3 jig of the indicated
cDNA fragments were bound by slot blot, were hybridized with the nuclear
run-on labeled RNA at 3.0 x 106 cpm/mI for 4 days at 42”C under
moderately stringent conditions. Following hybridization, the membranes
were washed for 15 mm twice at room temperature in 1 x sodium chloride
sodium phosphate EDTA, 0.1 % SDS, and once at 42”C in 0.1 x sodium
chloride sodium phosphate EDTA, 0.5% SDS. In addition to the probes
used for Northern analysis, a c-myc 340-nt XhoI-PvulI cDNA was used as
a positive control for transcriptional activity (1 7), and pGEM -3Z was used
for nonspecific hybridization. Autoradiography was performed with Du
Pont NEN Reflection film at - 70”C using an intensifying screen. Several
exposures were taken to ensure linearity of the films for densitometric
analysis.
Antibodies. The antibodies used were as follows: affinity-purified rab-
bit antimouse Bcl-x at a dilution of 1:200 (24); affinity-purified rabbit
antihuman BcI-2 (N-19) and Bax (P-19) at dilutions of 1:500 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA); rabbit antimouse Bax at a dilution of
1:2000; and rabbit antirat Bcl-2 at a dilution of 1:1000 (16).
Preparation of Cytoplasmlc Proteins, Nuclei, and Nuclear Extracts.
The isolation procedures for total, cytoplasmic, and nuclear protein frac-
tions were adapted from Brewer and Ross (54) and Beebee (55) with
modifications as described previously (44). The purity of the cytoplasmic
and nuclear fractions was characterized using two independent methods.
Nuclear protein fractions were also obtained from nuclei purified by high-
speed centrifugation through 2.1 M sucrose as described (1 8). Further
fractionation was accomplished by removing the outer membrane layer
from one half of the isolated nuclei as previously reported (44). Nuclear
NUN (0.3 M NaCI, 1 M urea, 1% NP-40, 25 mp￿i HEPES, pH 7.6, and 1 m￿i
DII) extract was prepared as described (56). The precipitated material
was resuspended in 1 x total protein buffer (5 m￿i Tris-HCI, pH 7.6, 0.5%
NP-40, supplemented with protease inhibitors, 50 jig/mI PMSF, 10 jig/mI
aprotinin, 10 jig/mI leupeptin) and sonicated in five 10-s bursts.
Immunoblot Analysis. lmmunoblothng experiments were carried out
according to standard protocols (57) using 15% Tris/glycmne SDS-poly-
acrylamide gels. Electrophoretic transfer and processing of the Western
blots was carried out as reported previously (44). Secondary antibodies
were coupled to horseradish peroxidase, and immunoreactive proteins
were detected using enhanced chemiluminescence.
Densitometry and Statistical Analysis. Video densitometry was ac-
complished using a Macintosh II (Apple Computer, Cupertino, CA) cou-
pled to a Data Translation DT2255 video digitizer (Data Translation, Marl-
boro, MA) and a JVC GX-N8 video camera (JVC Corporation of America,
Elmwood Park, NJ) as described previously (1 8). Quantitation of the
autoradiograms and fluorograms used the NIH Image 1.4 densitometric
analysis program. Nuclear run-ons were normalized to the ASGPR cDNA
and Northern blot hybridizations to the ASGP￿ mRNA (18). Statistical
analysis was performed using InStat (Version 2.1) for the ANOVA and
Bonferroni’s multiple comparison tests.
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